Lunai Bioworks (LNAI) Interest Coverage Ratio Growth (3y) (2015 - 2026)
Lunai Bioworks (LNAI) Interest Coverage Ratio Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-16.86% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Lunai Bioworks |
95.85 Mn |
92.70 Mn |
20,942.00 |
25.62% |
| Date | Value |
| Mar 31, 2026 |
25.62% |
| Dec 31, 2025 |
78.78% |
| Sep 30, 2025 |
28.91% |
| Jun 30, 2025 |
-57.07% |
| Mar 31, 2025 |
19.56% |
| Dec 31, 2024 |
12.14% |
| Sep 30, 2024 |
-36.63% |
| Jun 30, 2024 |
22.56% |
| Mar 31, 2024 |
-148.87% |
| Dec 31, 2023 |
24.00% |
| Sep 30, 2023 |
-16.97% |
| Jun 30, 2021 |
-801.34% |
| Mar 31, 2021 |
-37.89% |
| Dec 31, 2020 |
30.25% |
| Sep 30, 2020 |
69.17% |
| Mar 31, 2018 |
-73.04% |
| Dec 31, 2017 |
-72.96% |
| Sep 30, 2017 |
-240.22% |
| Jun 30, 2017 |
-114.32% |
| Mar 31, 2017 |
-46.17% |